Insider Selling: Crescent Biopharma (NASDAQ:CBIO) CEO Sells $28,819.00 in Stock
MarketBeat
Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) CEO Joshua Brumm sold 1,610 shares of the business's stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $17.90, for a total value of $28,819.00. Following the sale, the chief executive officer owned 279,602 shares of the company's stock, valued at approximately $5,004,875.80. This represents a 0.57% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
NASDAQ:CBIO